Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Neoplasms Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05110573
What this trial is testing

Single-centre Propensity Score-matched Comparison of Laparoscopic Versus Open Pancreatoduodenectomy

Who this might be right for
Pancreatic Neoplasms
General Hospital Groeninge 172
Early research (Phase 1)Study completedNCT02960594
What this trial is testing

HTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse

Who this might be right for
Breast CancerLung CancerPancreatic Cancer+6 more
Inovio Pharmaceuticals 93
Not applicableEnded earlyNCT01760694
What this trial is testing

Multi-Modality Therapy for Untreated Patients With Resectable or Marginally Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Southwestern Regional Medical Center 6
Not applicableUnknownNCT03033186
What this trial is testing

Everolimus TDM to Predict Long Term Toxicity

Who this might be right for
Breast CancerRenal Cell CarcinomaPancreatic Neuroendocrine Tumour+2 more
Maastricht University Medical Center 40
Not applicableLooking for participantsNCT06149546
What this trial is testing

Exploring the Impact of a Multi-modal Nutritional Intervention in Patients Undergoing Chemotherapy for Pancreatic Cancer (FEED Trial)

Who this might be right for
Pancreatic Cancer
Cancer Trials Ireland 70
Testing effectiveness (Phase 2)Looking for participantsNCT06761027
What this trial is testing

MFOLFIRINOX Plus Anlotinib and Sintilimab for Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic CancerMetastatic Pancreatic Cancer
Fujian Provincial Hospital 29
Testing effectiveness (Phase 2)Study completedNCT01529827
What this trial is testing

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more
Roswell Park Cancer Institute 94
Testing effectiveness (Phase 2)Study completedNCT00222469
What this trial is testing

Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
University of Oklahoma 50
Post-approval studies (Phase 4)UnknownNCT04357483
What this trial is testing

Effect of Thrombin-containing Collagen-based Hemostatic Matrix

Who this might be right for
Pancreatic Tumor
Asan Medical Center 60
Early research (Phase 1)Active Not RecruitingNCT05277766
What this trial is testing

Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer

Who this might be right for
Peritoneal CarcinomatosisPeritoneal MetastasesColorectal Cancer+5 more
University Hospital, Ghent 45
Not applicableStudy completedNCT04920019
What this trial is testing

Opioid Sparing Effect of Thoracic Epidural Analgesia for Open Upper Abdominal Surgery

Who this might be right for
HepatomaPancreas Cancer
Mahidol University 140
Large-scale testing (Phase 3)UnknownNCT04167007
What this trial is testing

FOLFOX vs Gemcitabine in Patients With Metastatic Pancreatic Cancer Non-fit to FOLFIRINOX

Who this might be right for
Pancreatic Adenocarcinoma
Assistance Publique - Hôpitaux de Paris 400
Testing effectiveness (Phase 2)UnknownNCT04289792
What this trial is testing

Split-course SBRT for Borderline Resectable and Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Fujian Medical University Union Hospital 27
Not applicableUnknownNCT03228095
What this trial is testing

Volatiles in Breath and Headspace Analysis - Diagnostic Markers

Who this might be right for
TuberculosisGastric CancerPeptic Ulcer+13 more
University of Latvia 3,000
Not applicableStudy completedNCT05483075
What this trial is testing

Feasibility of a Health Care Provider Guided Exercise Intervention Prior to Surgical Resection of Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
NYU Langone Health 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05637567
What this trial is testing

Perioperative Platelet Inhibition With Acetylsalicylic Acid in Patients With Resectable Tumors of the Pancreatic Head

Who this might be right for
Pancreatic Cancer Resectable
German Cancer Research Center 170
Not applicableTemporarily pausedNCT06653192
What this trial is testing

EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction (CARPEDIEM Trial)

Who this might be right for
Malignant Biliary ObstructionPancreatic CancerBiliary Tract Neoplasms
Hospital Universitari de Bellvitge 120
Testing effectiveness (Phase 2)Study completedNCT00075439
What this trial is testing

Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+6 more
National Cancer Institute (NCI) 90
Not applicableUnknownNCT03178812
What this trial is testing

Role of the Cystic Fluid Interleukins and Tumor Necrosis Factor (TNF) Levels in Characterizing Pancreatic Cysts Detected by Endoscopic Ultrasound (EUS)

Who this might be right for
Pancreatic Cancer
Hillel Yaffe Medical Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT04924075
What this trial is testing

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

Who this might be right for
Pheochromocytoma/ParagangliomaPancreatic Neuroendocrine TumorVon Hippel-Lindau Disease+2 more
Merck Sharp & Dohme LLC
Next Page
355